Kinnevik AB
STO:KINV B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kinnevik AB
STO:KINV B
|
SE |
|
H
|
Hubei Goto Biopharm Co Ltd
SZSE:300966
|
CN |
Income Statement
Earnings Waterfall
Kinnevik AB
Income Statement
Kinnevik AB
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
41
|
0
|
0
|
0
|
42
|
0
|
0
|
0
|
55
|
0
|
0
|
0
|
44
|
0
|
0
|
0
|
49
|
0
|
0
|
0
|
0
|
|
| Revenue |
2 907
N/A
|
2 534
-13%
|
1 408
-44%
|
1 689
+20%
|
1 689
N/A
|
2 299
+36%
|
2 299
N/A
|
1 689
-27%
|
1 689
N/A
|
3 640
+116%
|
3 640
N/A
|
3 538
-3%
|
3 538
N/A
|
929
-74%
|
929
N/A
|
936
+1%
|
936
N/A
|
491
-48%
|
491
N/A
|
23
-95%
|
23
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(329)
|
(422)
|
(389)
|
(396)
|
(424)
|
(366)
|
(331)
|
(312)
|
(302)
|
(306)
|
(333)
|
(361)
|
(378)
|
(422)
|
(419)
|
(408)
|
(409)
|
(381)
|
(418)
|
(437)
|
(441)
|
(424)
|
(375)
|
(332)
|
|
| Selling, General & Administrative |
(375)
|
(432)
|
(399)
|
(404)
|
(433)
|
(369)
|
(335)
|
(319)
|
(308)
|
(316)
|
(344)
|
(371)
|
(388)
|
(431)
|
(427)
|
(417)
|
(417)
|
(388)
|
(432)
|
(448)
|
(454)
|
(439)
|
(383)
|
(341)
|
|
| Other Operating Expenses |
46
|
10
|
10
|
8
|
9
|
3
|
4
|
7
|
6
|
10
|
11
|
10
|
10
|
9
|
8
|
9
|
8
|
7
|
14
|
11
|
13
|
15
|
8
|
9
|
|
| Operating Income |
2 578
N/A
|
2 112
-18%
|
1 019
-52%
|
1 293
+27%
|
1 265
-2%
|
1 933
+53%
|
1 968
+2%
|
1 377
-30%
|
1 387
+1%
|
3 334
+140%
|
3 307
-1%
|
3 177
-4%
|
3 160
-1%
|
507
-84%
|
510
+1%
|
528
+4%
|
527
0%
|
110
-79%
|
73
-34%
|
(414)
N/A
|
(418)
-1%
|
(424)
-1%
|
(375)
+12%
|
(332)
+11%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
(3 119)
|
16 029
|
34 369
|
39 825
|
54 285
|
41 463
|
20 884
|
13 411
|
2 782
|
(18 383)
|
(21 203)
|
(22 682)
|
(15 592)
|
(7 620)
|
(7 735)
|
(5 248)
|
(8 075)
|
(8 516)
|
(7 116)
|
(2 193)
|
(5 005)
|
(2 105)
|
500
|
(3 892)
|
|
| Total Other Income |
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(46)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(14)
|
|
| Pre-Tax Income |
(541)
N/A
|
18 141
N/A
|
35 388
+95%
|
41 106
+16%
|
55 550
+35%
|
43 396
-22%
|
22 852
-47%
|
14 782
-35%
|
4 169
-72%
|
(15 049)
N/A
|
(17 896)
-19%
|
(19 519)
-9%
|
(12 432)
+36%
|
(7 113)
+43%
|
(7 225)
-2%
|
(4 766)
+34%
|
(7 548)
-58%
|
(8 406)
-11%
|
(7 043)
+16%
|
(2 622)
+63%
|
(5 423)
-107%
|
(2 529)
+53%
|
125
N/A
|
(4 238)
N/A
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
(1)
|
(1)
|
(1)
|
(832)
|
(832)
|
(832)
|
(832)
|
(5)
|
(5)
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
892
|
|
| Income from Continuing Operations |
(542)
|
18 140
|
35 387
|
40 274
|
54 718
|
42 564
|
22 020
|
14 777
|
4 164
|
(15 054)
|
(17 901)
|
(19 519)
|
(12 432)
|
(7 113)
|
(7 225)
|
(4 766)
|
(7 548)
|
(8 406)
|
(7 043)
|
(2 623)
|
(5 424)
|
(2 530)
|
124
|
(3 346)
|
|
| Net Income (Common) |
(542)
N/A
|
18 140
N/A
|
35 387
+95%
|
40 274
+14%
|
54 718
+36%
|
42 564
-22%
|
22 020
-48%
|
14 777
-33%
|
4 164
-72%
|
(15 054)
N/A
|
(17 901)
-19%
|
(19 519)
-9%
|
(12 432)
+36%
|
(7 113)
+43%
|
(7 225)
-2%
|
(4 766)
+34%
|
(7 548)
-58%
|
(8 406)
-11%
|
(7 043)
+16%
|
(2 623)
+63%
|
(5 424)
-107%
|
(2 530)
+53%
|
124
N/A
|
(3 346)
N/A
|
|
| EPS (Diluted) |
-1.95
N/A
|
65.43
N/A
|
127.39
+95%
|
145.22
+14%
|
196.98
+36%
|
153.17
-22%
|
79.24
-48%
|
53.12
-33%
|
14.94
-72%
|
-53.88
N/A
|
-63.92
-19%
|
-69.83
-9%
|
-44.38
+36%
|
-25.32
+43%
|
-25.65
-1%
|
-16.96
+34%
|
-26.82
-58%
|
-29.86
-11%
|
-24.95
+16%
|
-9.47
+62%
|
-19.58
-107%
|
-9.13
+53%
|
0.44
N/A
|
-12.08
N/A
|
|